Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. - Wikidata - wikimedia - TriplyDB

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.

http://www.wikidata.org/entity/Q36134992

about

Cyclin D1 proteolysis: a retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells A nonsynonymous single-nucleotide polymorphism in the PDZ-Rho guanine nucleotide exchange factor (Ser1416Gly) modulates the risk of lung cancer in Mexican Americans Role of cell cycle regulators in lung carcinogenesis Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.Nuclear expression of p53, p21 and cyclin D1 is increased in bronchioloalveolar carcinoma.The gene expression of hepatic proteins responsible for DNA repair and cell proliferation in tamoxifen-induced hepatocarcinogenesis.Sex differences in estrogen receptor subcellular location and activity in lung adenocarcinoma cells YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes.Lung cancer. 9: Molecular biology of lung cancer: clinical implications.New molecular strategies for early lung cancer detection.CRABP I expression and the mediation of the sensitivity of human tumour cells to retinoic acid and irradiation.Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: biologic function and clinical significance.Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models.Prognostic significance of cyclin D1 expression in colorectal cancer: a meta-analysis of observational studies.Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas.Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck Pharmacogenetics of methotrexate.Mice lacking a transcriptional corepressor Tob are predisposed to cancer.Cell cycle regulation and its aberrations in human lung carcinoma.High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressor.Molecular pathology of non-small-cell lung cancer.The therapeutic potential of targeting the cell cycle.Evidence for the ubiquitin protease UBP43 as an antineoplastic target.Frequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohistochemistry Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients.Spontaneous Adenosquamous Carcinoma with Rapid Growth and EMT-like Changes in the Mammary Gland of a Young Adult Female BALB/c Mouse.Transforming growth factor-beta in cancer and metastasis.Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer.Activation of cyclin D1-related kinase in human lung adenocarcinoma.The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression.Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells.Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer.Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer Cyclin D1 overexpression, p16 loss, and pRb inactivation play a key role in pulmonary carcinogenesis and have a prognostic implication for the long-term survival in non-small cell lung carcinoma patients.Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trial.Cell-cycle markers and biosensors.Prognostic and predictive value of cell cycle deregulation in non-small-cell lung cancer.New biomarkers for lung cancer.Cell cycle inhibitors for the treatment of NSCLC.

P2860

Q28137940-B9EFF1C7-7930-49E4-B82B-9F513DF7109E Q28239827-7E43A8B9-A818-4D2E-ACB5-932C707A68F1 Q28394676-CA5EF539-3FEC-49DB-9B3B-B44C8E480902 Q30419853-D3F3E693-1CC5-4161-AABA-89B022C03F26 Q30682145-B6C2BD70-FF00-4B9F-AD77-7CD47898D1FD Q30957901-E154A14A-3EE5-42BC-B4B2-4DD3844509A8 Q33695898-36EA759A-1B91-43C2-8B86-4349576BFBA4 Q33757057-651E433B-CF1B-4FA9-BD41-B65BABB9FA83 Q33972805-560B973E-88EE-4E39-8173-2CB2D6FEA56E Q33989030-22C4EFCB-CE11-416F-BC44-29C1FB39649C Q34288783-C15F1928-0B33-4B1C-B087-7D81C5C19E15 Q34733433-F78040CA-47FF-4CF8-8B59-C3C0C7118B2A Q35025931-0FC34EC8-DDF2-4A0E-A54B-7371DC6A1D39 Q35146690-547E0500-9EE5-41EE-93C7-50751CAE6D45 Q35753340-24C5538D-F780-4D5F-BA63-379003FA4DBF Q35788347-7EE90F68-D0F1-4E9D-861D-5397F39B04FA Q35911142-4C389263-9FA3-47AE-8FD9-D8587EFDF193 Q35965343-97C52DA2-F0C5-49D4-8FBD-81B14E2C2612 Q36060004-572A22B8-1991-4FB3-93DD-B7562DC4C81D Q36136114-F1FA9D8E-E7EC-427F-A3EF-E202FDAAD258 Q36155104-AD44F4FD-DDC2-4021-8167-53E8D2EA9573 Q36181206-5CB470A7-AF58-4A63-B594-C76F748A1386 Q36223149-36B87CD5-72D2-4547-B9BE-FC30D56F42E8 Q36292511-E083CB18-7E90-4D6A-8D10-63972B2E0690 Q36422016-618ECA34-DA18-4FF4-870A-CEFFC54E4FAF Q36455141-33D2E624-00C2-42A2-B803-F99DA4FEB95C Q36585129-EBBEFEBA-B404-4850-9872-A5C5F7449F99 Q36617988-1D78D268-F18A-4BB3-AC89-5EAC724DA61C Q36618912-B41CFFD8-787C-42AA-9569-17430826DC05 Q36619736-DDE83EEC-7702-4D14-B3CC-11EE4F46C158 Q36622224-88E396BB-2A26-4AA3-9B6A-0FD195E535DD Q36641066-5780CAB9-73EF-4BFB-A9E7-3AE470E52966 Q36641208-DDB6E955-4352-49CE-8568-2485777C0D65 Q37093273-629F066F-70F6-4677-A40D-5F3CF49048F4 Q37230186-5D8E0C44-79F3-4111-851A-53B69D3BAE74 Q37509502-80378DEF-111E-46F5-88B9-A74CF1BCFA28 Q37732060-E14BF628-2D9E-4275-B5EF-09BADDBAA5DD Q37996270-0810DBB6-FF58-45EA-80D9-B4960819131E Q38089079-5510408B-13A8-418B-B435-F0904D70893C Q38199197-6C48D476-2182-4F1B-B4AA-E42915B947E4

P2860

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.

http://www.wikidata.org/entity/Q36134992

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Prognostic significance of CCN ...... ed non-small-cell lung cancer.

@ast

Prognostic significance of CCN ...... ed non-small-cell lung cancer.

@en

type

label

Prognostic significance of CCN ...... ed non-small-cell lung cancer.

@ast

Prognostic significance of CCN ...... ed non-small-cell lung cancer.

@en

prefLabel

Prognostic significance of CCN ...... ed non-small-cell lung cancer.

@ast

Prognostic significance of CCN ...... ed non-small-cell lung cancer.

@en

P1433

Q36134992-6D12812B-7D99-4DB6-9E79-4E6A19E7CBBF

P1476

Q36134992-0BB29865-A62D-45F3-955D-44B5759EAE23

P2093

Q36134992-069E6DCA-F596-4657-A431-4A644BCC6202

Q36134992-178D09AC-4785-45CA-9E33-A3BBA4FFC30E

Q36134992-250E75A0-4CF0-4DE0-B0E7-F47FE0D2C8F9

Q36134992-515E1FC9-EF3E-4F80-85FC-C900F7D08F02

Q36134992-543B2FE1-C03F-46EF-A3CF-552E722B4DE7

Q36134992-9083488F-8F7E-4D6D-8528-5C00037D7424

Q36134992-EE255D97-D433-4FF2-813E-0B81063C7703

P2860

Q36134992-01E0B06C-033A-4E89-BCCE-E72B79DEBB7C

Q36134992-03DFB240-6B14-4B90-8CE2-C42874C9D828

Q36134992-05E11132-71BF-4603-A458-C7B010C7480B

Q36134992-09605B02-2DB5-40B3-9817-39020832F0B6

Q36134992-0C7D18EA-2D5F-4F35-AEDB-64EFD0771C52

Q36134992-1790B069-BC69-4CCA-B965-4285F2BC89A4

Q36134992-1E824F9D-2A30-4E1B-BB88-BF36001B5EFF

Q36134992-1F050836-C61E-4B7E-A8B0-67167FE4BF2E

Q36134992-313FBF61-03C5-4864-B538-364F61602C4C

Q36134992-380DA5FC-49A1-4ECE-83AB-A39DD675B8D2

P2888

Q36134992-7A07AC8A-2C67-40F7-9DD1-84AB0F7B801A

P304

Q36134992-BF92A479-D65D-46EA-B98C-F7C1FB7A469C

P31

Q36134992-EC6453FA-FDDA-4AC6-A4EF-C0F0EABBE91A

P356

Q36134992-3A1E7BD5-EBC5-4D37-BEA7-E1034D5FF32B

P407

Q36134992-E996D70D-F0B3-41A5-B9EB-9B92913C1671

P433

Q36134992-66087626-8B8C-478E-A36D-DFB0285D316A

P478

Q36134992-6A3311FB-587E-4288-9A62-D34E439A0DAB

P577

Q36134992-4407C1C8-BE21-4F19-A0FE-201ECB516FAB

P5875

Q36134992-5F965F70-8998-481A-9364-A3FF0D1498A2

P698

Q36134992-55F668B8-E69C-4F30-B1D9-0BD237B2DC56

P921

Q36134992-C898DD2C-288C-43B4-80B8-050D4F768F44

P932

Q36134992-30B8B668-6B60-4B73-A7FD-B6D202ECA9BD

P356

P1433

British Journal of Cancer

P1476

Prognostic significance of CCN ...... ed non-small-cell lung cancer.

@en

P2093

Altermatt HJ

http://www.w3.org/2001/XMLSchema#string

Betticher DC

http://www.w3.org/2001/XMLSchema#string

Cerny T

http://www.w3.org/2001/XMLSchema#string

Hasleton PS

http://www.w3.org/2001/XMLSchema#string

Heighway J

http://www.w3.org/2001/XMLSchema#string

Ryder WD

http://www.w3.org/2001/XMLSchema#string

Thatcher N

http://www.w3.org/2001/XMLSchema#string

P2860

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

Characterization of a candidate bcl-1 gene

A novel cyclin encoded by a bcl1-linked candidate oncogene

Human D-type cyclin

Cyclin D1 is a nuclear protein required for cell cycle progression in G1

Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast

Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation

G1 phase progression: cycling on cue

A general method for isolation of high molecular weight DNA from eukaryotes

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

P2888

P304

294-300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1996.52

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

1996-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14638860

http://www.w3.org/2001/XMLSchema#string

P698

8562333

http://www.w3.org/2001/XMLSchema#string

P921

P932

2074441

http://www.w3.org/2001/XMLSchema#string